Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia

Franco Locatelli; J. A. Whitlock; C. Peters; C. Chen-Santel; V. Chia; R. M. Dennis; K. M. Heym; A. J. Katz; M. A. Kelsh; R. Sposto; H. Tu; C. A. Tuglus; A. Verma; L. Vinti; J. J. Wilkes; N. Zubarovskaja; G. Zugmaier; A. von Stackelberg; W. Sun

doi:10.1038/s41375-020-0770-8

Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia

Franco Locatelli^*
, J. A. Whitlock
, C. Peters
, C. Chen-Santel
, V. Chia
, R. M. Dennis
, K. M. Heym
, A. J. Katz
, M. A. Kelsh
, R. Sposto
, H. Tu
, C. A. Tuglus
, A. Verma
, L. Vinti
, J. J. Wilkes
, N. Zubarovskaja
, G. Zugmaier
, A. von Stackelberg
, W. Sun

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

NO ABSTRACT

Lingua originale	Inglese
pagine (da-a)	2473-2478
Numero di pagine	6
Rivista	Leukemia
Volume	34
Numero di pubblicazione	9
DOI	https://doi.org/10.1038/s41375-020-0770-8
Stato di pubblicazione	Pubblicato - 2020

All Science Journal Classification (ASJC) codes

Ematologia
Oncologia
Ricerca sul Cancro

Keywords

ALL
BLINATUMOMAB

Accesso al documento

10.1038/s41375-020-0770-8

Altri file e collegamenti

Cita questo

Locatelli, F., Whitlock, J. A., Peters, C., Chen-Santel, C., Chia, V., Dennis, R. M., Heym, K. M., Katz, A. J., Kelsh, M. A., Sposto, R., Tu, H., Tuglus, C. A., Verma, A., Vinti, L., Wilkes, J. J., Zubarovskaja, N., Zugmaier, G., von Stackelberg, A., & Sun, W. (2020). Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia. Leukemia, 34(9), 2473-2478. https://doi.org/10.1038/s41375-020-0770-8

@article{968141f04e1d48a3bac4eeb48d8117e9,

title = "Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia",

abstract = "NO ABSTRACT",

keywords = "ALL, BLINATUMOMAB, ALL, BLINATUMOMAB",

author = "Franco Locatelli and Whitlock, \{J. A.\} and C. Peters and C. Chen-Santel and V. Chia and Dennis, \{R. M.\} and Heym, \{K. M.\} and Katz, \{A. J.\} and Kelsh, \{M. A.\} and R. Sposto and H. Tu and Tuglus, \{C. A.\} and A. Verma and L. Vinti and Wilkes, \{J. J.\} and N. Zubarovskaja and G. Zugmaier and \{von Stackelberg\}, A. and W. Sun",

year = "2020",

doi = "10.1038/s41375-020-0770-8",

language = "English",

volume = "34",

pages = "2473--2478",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "9",

}

Locatelli, F, Whitlock, JA, Peters, C, Chen-Santel, C, Chia, V, Dennis, RM, Heym, KM, Katz, AJ, Kelsh, MA, Sposto, R, Tu, H, Tuglus, CA, Verma, A, Vinti, L, Wilkes, JJ, Zubarovskaja, N, Zugmaier, G, von Stackelberg, A & Sun, W 2020, 'Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia', Leukemia, vol. 34, n. 9, pagg. 2473-2478. https://doi.org/10.1038/s41375-020-0770-8

TY - JOUR

T1 - Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia

AU - Locatelli, Franco

AU - Whitlock, J. A.

AU - Peters, C.

AU - Chen-Santel, C.

AU - Chia, V.

AU - Dennis, R. M.

AU - Heym, K. M.

AU - Katz, A. J.

AU - Kelsh, M. A.

AU - Sposto, R.

AU - Tu, H.

AU - Tuglus, C. A.

AU - Verma, A.

AU - Vinti, L.

AU - Wilkes, J. J.

AU - Zubarovskaja, N.

AU - Zugmaier, G.

AU - von Stackelberg, A.

AU - Sun, W.

PY - 2020

Y1 - 2020

N2 - NO ABSTRACT

AB - NO ABSTRACT

KW - ALL

KW - BLINATUMOMAB

KW - ALL

KW - BLINATUMOMAB

UR - https://publicatt.unicatt.it/handle/10807/228272

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85079752904&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079752904&origin=inward

U2 - 10.1038/s41375-020-0770-8

DO - 10.1038/s41375-020-0770-8

M3 - Article

SN - 0887-6924

VL - 34

SP - 2473

EP - 2478

JO - Leukemia

JF - Leukemia

IS - 9

ER -

Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo